# Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy Adults

> **NCT04886050** · PHASE1 · COMPLETED · sponsor: **LG Chem** · enrollment: 23 (actual)

## Conditions studied

- Gout
- Hyperuricemia

## Interventions

- **DRUG:** LC350189 Tablet
- **DRUG:** LC350189 Capsule

## Key facts

- **NCT ID:** NCT04886050
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-31
- **Primary completion:** 2021-09-16
- **Final completion:** 2021-12-10
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2022-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04886050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04886050, "Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04886050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*